1. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high- risk groups 
Michael T. Jaklitsch, MD, Francine L. Jacobson, MD, MPH, John H.M. Austin, MD, John K. Field, MA, PhD BDS, FRCPath, James R. Jett, MD, Shaf Keshavjee, MSc, FRCSC, MD, Heber MacMahon, MB, BCh, James L. Mulshine, MD, Reginald F. Munden, MD, DMD, MBA, Ravi Salgia, MD, PhD, Gary M. Strauss, MD, Scott J. Swanson, MD, William D. Travis, MD, David J. Sugarbaker, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 144, Issue 1, Pages (July 2012)
DOI: /j.jtcvs
Copyright © Terms and Conditions

2. Figure 1
AATS lung cancer screening guidelines category 1 for highest risk. CT, Computed tomography; LDCT, low-dose computed tomography.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions

3. Figure 2
AATS lung cancer screening guidelines for combined risk or lung cancer survivor. CT, Computed tomography; LDCT, low-dose computed tomography; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions

4. Figure 3
AATS lung cancer screening guidelines for solid nodules on low-dose computed tomography (LDCT). PET/CT, Positron emission tomography/computed tomography.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions

5. Figure 4
AATS lung cancer screening guidelines for ground-glass nodule. LDCT, Low-dose computed tomography.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions

6. Figure 5
AATS lung cancer screening guidelines of new nodule on screening scan on low-dose computed tomography (LDCT). PET/CT, Positron emission tomography/computed tomography.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions

7. Figure 6
Annual screening should produce greater than 20% reduction in lung cancer–specific mortality. There is an increase in detected cancers in the LDCT arm during the active screening period, but not after the start of the observation period (arrow).
Reprinted with permission.1 Copyright the Massachusetts Medical Society.
The Journal of Thoracic and Cardiovascular Surgery  , 33-38DOI: ( /j.jtcvs )
Copyright © Terms and Conditions